Erhong Meng
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Retraction: Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
Journal: Oncotarget
Published: July 03, 2023
Long-term response to camrelizumab in a pretreated metastatic mixed testicular germ-cell tumor patient with co-mutations in DNA damage-repair genes.
Journal: Immunotherapy
Published: January 17, 2023
Dramatic response to local radiotherapy in a refractory metastatic mediastinal yolk sac tumor patient harboring a germline BRCA2 frameshift mutation: a case report.
Journal: Cancer biology & therapy
Published: May 16, 2022
Complete and durable response to crizotinib in a patient with malignant pleural mesothelioma harboring CD74-ROS1 fusion.
Journal: Journal of cancer research and clinical oncology
Published: March 17, 2022
Homozygous deletion of the HLA-B gene as an acquired-resistance mechanism to nivolumab in a patient with lung adenocarcinoma: a case report.
Journal: Annals of translational medicine
Published: July 02, 2021
Case report: identification of ERC1-RET fusion in a patient with pancreatic ductal adenocarcinoma.
Journal: Gland surgery
Published: June 22, 2021
Emerging roles and underlying molecular mechanisms of DNAJB6 in cancer.
Journal: Oncotarget
Published: February 03, 2016
Last Updated: 09/26/2026